$AKTS SEC Filings

Filed On	Filing
24 Sep 2026	Form 4: Czibere Akos, Chief Medical Officer Received 12,500 shares by exercise or conversion ($61.9K) · Sold 12,500 shares ($259K)
23 Sep 2026	144
13 Aug 2026	10-Q
13 Aug 2026	8-K: Results of Operations and Financial Condition
21 Jul 2026	Form 4: Herrmann Ken, Director Received 4,856 shares by exercise or conversion ($2.86K) · Sold 4,856 shares ($119K)
20 Jul 2026	Form 4: Herrmann Ken, Director Received 3,065 shares by exercise or conversion ($245) · Sold 3,065 shares ($77.3K)
20 Jul 2026	144
17 Jul 2026	144
10 Jul 2026	Form 4: Ron-Bigger Shulamit, Chief Operating Officer Received 50,000 shares by exercise or conversion ($183K) · Sold 50,000 shares ($1.39M)
10 Jul 2026	Form 4: Czibere Akos, Chief Medical Officer Received 50,000 shares by exercise or conversion ($248K) · Sold 50,000 shares ($1.39M)
08 Jul 2026	144
08 Jul 2026	144
14 May 2026	SCHEDULE 13G
11 May 2026	10-Q
11 May 2026	8-K: Results of Operations and Financial Condition
16 Apr 2026	Form 4: Gormley Glenn, Director Granted 37,866 Stock Option (Right to Buy)
16 Apr 2026	Form 3: Gormley Glenn, Director No securities owned
16 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
31 Mar 2026	8-K: Results of Operations and Financial Condition
30 Mar 2026	10-K

Comments